Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gerald G. Colella, a director at MKS Inc (NASDAQ: MKSI), reported the sale of 20,000 common shares for approximately $5.06 million in two transactions filed on a Form 4 with the SEC. The trades took place on February 20 and February 24, 2026, at weighted average prices of $252.8999 and $253.9675, respectively. The sales occurred while MKSI shares w…
Lucid Capital Markets increased its price target for Palvella Therapeutics (PVLA) to $241 from $212 and kept a Buy rating after the company released Phase 3 SELVA trial data for QTORIN 3.9% rapamycin anhydrous gel. The trial reported a mean mLM-IGA improvement of +2.13 and an 86% responder rate. Management has provided pricing guidance and a commer…
PNC Financial Services Group CEO William S. Demchak sold 50,000 shares on February 20, 2026, for about $11.5 million at a weighted average price of $230.88. The same day included additional internal share movements tied to restricted stock unit vesting and tax-cover sales. PNC reported stronger-than-expected fourth-quarter 2025 core EPS, prompting …
Carnival (CCL) is riding strong booking trends and visible margin improvement driven by debt reduction and lower interest costs. At $31.54 the stock trades at mid-teens P/E with EV/EBITDA below 10 and free cash flow of roughly $2.6B — a setup where operational leverage and cash-flow conversion can drive a 15-25% move higher if bookings and onboard …
The U.S. Securities and Exchange Commission has revised its internal enforcement manual to provide greater uniformity in how it notifies and interacts with subjects of investigations. Key changes include extending the standard response period to four weeks for Wells notices and guaranteeing an opportunity to meet with staff within four weeks of a r…
U.S. authorities announced sanctions on four individuals and three entities for roles in acquiring and distributing cyber tools deemed harmful to U.S. national security. The Department of State also applied intellectual property-related designations under the Protecting American Intellectual Property Act to one person and two entities in connection…
Kingstone Companies (KINS) is a small Northeast P&C insurer trading at a single-digit P/E with 29% reported ROE, low leverage and strong free cash flow. We think the shares can rally to the mid-$20s as underwriting performance stabilizes and the market re-rates a high-ROE, capital-efficient insurer. Trade plan, catalysts and risks below.
Morgan Stanley has moved to a Cautious stance on the U.S. liquefied natural gas sector, citing about 200 million tonnes per annum of new global capacity under construction that is due between 2025 and 2030. The bank expects annual supply additions to peak in 2027-2028 and forecasts weaker Japan Korea Marker (JKM) prices, a combination it says will …
Ten years after the inaugural liquefied natural gas shipment departed from Louisiana, the United States has become the world’s largest supplier of LNG. Supported by plentiful domestic gas, competitive feedgas costs and flexible contracts, U.S. exporters are accelerating capacity additions that industry participants say could roughly double output o…
Peter Mandelson, 72, was released from police custody on Tuesday after being arrested in London on suspicion of misconduct in public office. His lawyers say the detention followed an unfounded claim that he intended to relocate permanently overseas. The arrest occurs amid a criminal probe that began after the government passed correspondence betwee…
Wedbush reaffirmed an Outperform rating and a $340 price target on IBM after the stock plunged following an Anthropic announcement about COBOL modernization. Analysts note IBM’s entrenched mainframe presence, strategic AI partnerships, and services that support migration and compliance. Other firms including Evercore ISI and Jefferies have also rei…
Leerink Partners reaffirmed an Outperform rating and a $24.00 price target for Fulcrum Therapeutics after the release of full Phase 1b PIONEER results for pociredir in sickle cell disease. The firm continues to view the drug positively and estimates a material lead over competitors, while broader market reactions and other broker opinions remain mi…
Two Democratic state attorneys general announced a multistate lawsuit challenging recent federal changes to the childhood immunization schedule and alterations to the CDC advisory panel. The complaint, to be filed in Northern California federal court, contends the updated CDC guidance and personnel moves were unlawful and could depress vaccination …
Emeren Group Ltd (SOL) is a sub-$100M market-cap renewable developer with electricity generation as its core revenue. Technicals show bullish momentum and the company operates across China and several European markets. This trade idea treats SOL as a speculative, event-driven long: buy at $1.86, stop at $1.40, target $2.40 over a mid-term horizon o…
Progressive Corp Chief Investment Officer Jonathan S. Bauer executed a stock sale totaling roughly $460,111 on February 23, following recent tax-withholding and the vesting of performance-based restricted stock units. The transaction coincides with Progressive shares trading close to their 52-week low, while the company reported a modest increase i…
A bipartisan group of U.S. senators filed a resolution supporting Ukraine on Tuesday just hours before President Donald Trump delivered his nationally televised State of the Union address. Led by Senators Jeanne Shaheen and Thom Tillis, and backed by at least 26 co-sponsors split roughly evenly between the two parties, the measure expresses condole…
Tuesdays trading produced pronounced moves across market-cap tiers as select corporate announcements and earnings results pushed individual stocks sharply higher or lower. Advanced Micro Devices jumped after an announced AI infrastructure collaboration, while Keysight Technologies surged after reporting stronger-than-expected results and upbeat gui…
Earnings season advances with a substantial roster of companies set to release quarterly results on Wednesday, February 25, 2026. The calendar features major technology names including Nvidia, Salesforce, Synopsys and Snowflake, as well as financial and consumer companies. The published schedule lists estimated earnings per share and estimated reve…
Market participants face a busy slate on Wednesday, February 25, 2026, with the Energy Information Administration's weekly crude oil inventory report and remarks from U.S. President Trump expected to be the main market-moving items. A number of additional data points and events - from the 5-year Treasury note auction to multiple EIA fuel and refine…
Bayer AG has sued Johnson & Johnson in federal court in New York, alleging that J&J carried out a misleading advertising campaign for its prostate cancer drug Erleada that falsely claimed a 51% lower risk of death versus Bayer’s Nubeqa. The complaint contends the comparison relied on a retrospective real-world analysis with unequal patient groups a…
Baird trimmed its price target for Highwoods Properties Inc. to $29 from $30 while retaining a Neutral rating. The firm pointed to investor fatigue around the company's out-year earnings growth narrative and said recent transactions have pushed anticipated growth into 2027. The move comes amid broader weakness in the office sector and mixed quarter…
The U.S. Embassy in Jerusalem announced that U.S. consular officers will provide routine passport services in the Efrat settlement on Friday, February 27, marking the first time American officials have offered on-site consular services inside a West Bank settlement. The embassy said it plans comparable visits to Ramallah, the settlement of Beitar I…
MoonLake is a speculative buy on a high-impact regulatory binary: sonelokimab still appears to have a credible pathway to a Biologics License Application (BLA) win. With limited publicly circulated financials available in recent feeds, this trade treats the stock as a clinical-stage biotech binary with asymmetric upside if the BLA clears and define…
Tarsus (TARS) stock has re-rated on early commercial traction for XDEMVY and a positive technical backdrop. The company’s market cap sits around $3.2B with a tight float and elevated short interest — a setup that can amplify moves. This trade idea proposes a long entry near $75.61 with a $115 target over a 180 trading-day horizon and a stop at $60 …
<p>Nintendo's pullback has created a tactical buying opportunity. With market cap near $71.2B, a modest dividend yield and strong Switch 2 unit momentum, the company looks better positioned to benefit from high-quality IP and distribution control than to be disrupted by early-stage AI game builders. Technicals show oversold conditions but improving…
